293 research outputs found
Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors
cGMP-Dependent Protein Kinase II Modulates mPer1 and mPer2 Gene Induction and Influences Phase Shifts of the Circadian Clock
Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients
This study was designed to (a) estimate the contribution of tacrolimus nephrotoxicity to episodes of renal allograft dysfunction investigated by needle biopsy, (b) describe the temporal evolution of nephrotoxicity and its response to therapy, and (c) ascertain how often renal dysfunction is associated with concurrent extra-renal toxicity. Patients were selected based on a rising serum creatinine, normal ultrasound, and biopsy findings leading to a reduction in the dose of tacrolimus and a fall in serum creatinine. Twenty two (17%) cases of nephrotoxicity were identified amongst 128 consecutive kidney transplant biopsies with sufficient clinical data for analysis. There were 13 males and 9 females, 17-75 yr in age. Tacrolimus was administered initially as a 0.075-0.1 mg/kg/d IV continuous infusion followed by an oral dose of 0.15 mg/kg twice daily. The onset of nephrotoxicity in this study occurred 1-156 wk post-operatively. The mean baseline creatinine was 212.2 ± 168.0 μmol/l (range 88.4-875.2) and rose 40.6% ± 14.2% (range 11-66) during episodes of nephrotoxicity (p 5.0 mequiv./l was recorded in 9/22 (41%) cases. Three or more elevations in blood glucose > 7.7 mmol/l (140 mg/dl) were recorded in 4/11 (36%) non-diabetic patients. Hand tremors were seen in two (9%) cases and elevated diastolic blood pressure > 90 mmHg in seven (32%) patients. In conclusion, tacrolimus nephrotoxicity accounted for 17% of graft dysfunction episodes investigated by biopsy. Concurrent hyperglycemia, hyperkalemia, or tremors were noted in several patients. Nephrotoxicity responded well to reduction in the drug dosage
A Methodology to Account for the Finger Non-Uniformity in Photovoltaic Solar Cell
Abstract In this work we investigate the impact of a non-uniform finger in the front-side metallization on the performance of c-Si solar cells. For this purpose, we propose a methodology based on a mixed-mode simulation approach, which allows evaluating the solar cell properties by performing both numerical device simulations and circuit simulations. The finger roughness profile is modeled by means of Gaussian function. The impact of roughness on the solar cell efficiency is studied as a function of mean finger height, mean finger width and finger resistivity. The proposed methodology has been applied to typical roughness profiles realized with two different metallization techniques, the conventional single screen-printing (SP) and the double screen-printing (DP)
Improving splenic conservation rate after trauma by applying a protocol for non-operative management and follow-up: A propensity-score analysis
Background: There are shared guidelines about Non-Operative Management (NOM) of splenic injuries, but some unanswered questions remain. The aim of the present study is to establish the usefulness of a standardized protocol for management and follow-up of NOM patients with splenic injuries. Methods: Multicenter retrospective observational study including patients with major blunt trauma (ISS.15) with splenic injuries managed between January 1st 2014 and December 31st 2016 in two Italian I level Trauma Centers: one with a standardized management and follow-up protocol for NOM (Bufalini Hospital, Cesena, BH), and the other without it (ASST Papa Giovanni XXIII Hospital, Bergamo, PG23H). Comparison between patients' outcomes were performed and a propensity score model was calculated. Results: 47 patients managed in BH and 49 patients in PG23H were included. In BH, a higher proportion of patients was treated with NOM (72.3 % vs. 53.1 %, p ¼ 0.051). There was no difference in complication rate and mortality in patients treated with NOM in the two hospitals. A borderline significant trend to a higher NOM failure rate in PG23H was found (BH 0.0 % vs. PG23H 11.3 %, p ¼ 0.076). The total splenic conservation rate was significantly higher in BH (BH 72.3 % vs. PG23H 46.9 %, p ¼ 0.011). After the Propensity Score based matching, 72 patients were included and the total splenic conservation rate was significantly higher in BH (BH: 77.8 % vs. PG23H: 50.9 %, p ¼ 0.014). Conclusions: The application of a protocol for in-hospital management and follow-up for NOM of patients with splenic injury could decrease the NOM failure rate and improve splenic conservation rate
LANCL1 binds abscisic acid and stimulates glucose transport and mitochondrial respiration in muscle cells via the AMPK/PGC-1α/Sirt1 pathway
Objective: Abscisic acid (ABA) is a plant hormone also present and active in animals. In mammals, ABA regulates blood glucose levels by stimulating insulin-independent glucose uptake and metabolism in adipocytes and myocytes through its receptor LANCL2. The objective of this study was to investigate whether another member of the LANCL protein family, LANCL1, also behaves as an ABA receptor and, if so, which functional effects are mediated by LANCL1. Methods: ABA binding to human recombinant LANCL1 was explored by equilibrium-binding experiments with [3H]ABA, circular dichroism, and surface plasmon resonance. Rat L6 myoblasts overexpressing either LANCL1 or LANCL2, or silenced for the expression of both proteins, were used to investigate the basal and ABA-stimulated transport of a fluorescent glucose analog (NBDG) and the signaling pathway downstream of the LANCL proteins using Western blot and qPCR analysis. Finally, glucose tolerance and sensitivity to ABA were compared in LANCL2−/− and wild-type (WT) siblings. Results: Human recombinant LANCL1 binds ABA with a Kd between 1 and 10 μM, depending on the assay (i.e., in a concentration range that lies between the low and high-affinity ABA binding sites of LANCL2). In L6 myoblasts, LANCL1 and LANCL2 similarly, i) stimulate both basal and ABA-triggered NBDG uptake (4-fold), ii) activate the transcription and protein expression of the glucose transporters GLUT4 and GLUT1 (4-6-fold) and the signaling proteins AMPK/PGC-1α/Sirt1 (2-fold), iii) stimulate mitochondrial respiration (5-fold) and the expression of the skeletal muscle (SM) uncoupling proteins sarcolipin (3-fold) and UCP3 (12-fold). LANCL2−/− mice have a reduced glucose tolerance compared to WT. They spontaneously overexpress LANCL1 in the SM and respond to chronic ABA treatment (1 μg/kg body weight/day) with an improved glycemia response to glucose load and an increased SM transcription of GLUT4 and GLUT1 (20-fold) of the AMPK/PGC-1α/Sirt1 pathway and sarcolipin, UCP3, and NAMPT (4- to 6-fold). Conclusions: LANCL1 behaves as an ABA receptor with a somewhat lower affinity for ABA than LANCL2 but with overlapping effector functions: stimulating glucose uptake and the expression of muscle glucose transporters and mitochondrial uncoupling and respiration via the AMPK/PGC-1α/Sirt1 pathway. Receptor redundancy may have been advantageous in animal evolution, given the role of the ABA/LANCL system in the insulin-independent stimulation of cell glucose uptake and energy metabolism
Experimental analysis of variability in WS-based devices for hardware security
This work investigates the variability of tungsten disulfide (WS)-based
devices by experimental characterization in view of possible application in the
field of hardware security. To this aim, a preliminary analysis was performed
by measurements across voltages and temperatures on a set of seven
Si/SiO/WS back-gated devices, also considering the effect of different
stabilization conditions on their conductivity. Obtained results show
appreciable variability in the conductivity, while also revealing similar
dependence on bias and temperature across tested devices. Overall, our analysis
demonstrates that WS-based devices can be potentially exploited to ensure
adequate randomness and robustness against environmental variations and then
used as building blocks for hardware security primitives
Momentos oportunos de control con fungicidas de enfermedades de final de ciclo en soja
Entre las limitantes que presenta el cultivo de soja, se encuentran las llamadas enfermedades de fin de ciclo (EFC). En los últimos años, en la zona de Pergamino se destacaron por su prevalencia, incidencia y severidad la mancha marrón (Septoria glycines) y el tizón de la hoja y mancha púrpura de la semilla (Cercospora kikuchii, Cercospora spp.) (Distefano et al., 2017). Las EFC son causadas por hongos necrotróficos que sobreviven en semilla y rastrojo y afectan hojas, tallos, vainas y granos.EEA PergaminoFil: Pastore, M. Nueva AgronomÃa Chacabuco; ArgentinaFil: Couretot, Lucrecia. Instituto Nacional de TecnologÃa Agropecuaria (INTA). Estación Experimental Agropecuaria Pergamino. FitopatologÃa; ArgentinaFil: Samoiloff, Anabella. Instituto Nacional de TecnologÃa Agropecuaria (INTA). Estación Experimental Agropecuaria Pergamino. FitopatologÃa; ArgentinaFil: Magnone, Gerardo. Instituto Nacional de TecnologÃa Agropecuaria (INTA). Estación Experimental Agropecuaria Pergamino. FitopatologÃa; ArgentinaFil: Russián, Hernan DarÃo. Instituto Nacional de TecnologÃa Agropecuaria (INTA). Estación Experimental Agropecuaria Pergamino. FitopatologÃa; ArgentinaFil: Labatte, MatÃas. Instituto Nacional de TecnologÃa Agropecuaria (INTA). Estación Experimental Agropecuaria Pergamino. FitopatologÃa; Argentin
- …